Cirugía cardiovascular en España en el año 2019. Registro de intervenciones de la Sociedad Española de Cirugía Cardiovascular y Endovascular

Caballero, Gregorio Cuerpo; Menéndez, José López; López, Luz Polo; Hernández, Tomasa Centella; Carnero-Alcázar, Manuel; Fuster, Rafael García; García-Verdugo, Pilar Gascón; Aroca, José Miguel Barquero

doi:10.1016/j.circv.2021.01.004

Cited by 3 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hospital mortality was 3.7%, which is slightly higher than that calculated by preoperative EuroSCORE II (3.5%) but lower than the published registry of the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE) in 2019 than was 5.75% for this type of intervention ( 22 ). The stay both in the ICU and in the hospital for both the groups was short, especially in the case of the concomitant surgery group given their complexity.…”

Section: Discussionmentioning

confidence: 54%

Outcomes of rapid deployment aortic valve replacement with concomitant cardiac procedures

Gonzalez-Barbeito,

Arribas Leal,

Jimenez Alfaro

et al. 2023

J Thorac Dis

View full text Add to dashboard Cite

Background Rapid deployment aortic valve replacement (RD-AVR) has been recently introduced with encouraging results. Outcomes of isolated RD-AVR include good hemodynamic profile, facilitation of minimally invasive techniques, and reduction of surgical times. However, role of this prosthesis in concomitant surgery is not well known. Methods In 2016, we formed a registry to monitor the introduction of this prosthesis, RApid Deployment Aortic Replacement (RADAR). We aim to report mid-term outcomes focusing on patients who had RD-AVR combined with other surgical procedures. Results Between July 2012 and February 2021, 370 patients were included in this registry (mean age, 75.8±8.0 years; 64.32% male; mean EuroSCORE II, 3.5±2.8). Of these, 128 (34.59%) had concomitant procedures including myocardial revascularization surgery in 69 patients (53.91%), surgery on the ascending aorta in 34 (26.56%), and procedures on other valves in 10 patients (7.81%). There were no significant differences between the isolated AVR and concomitant AVR groups in postoperative complications, in-hospital mortality (4.72% vs. 3.32%, P=0.524), or hemodynamic behavior of these prostheses. Three-year survival was 83.73% and 89.89% in the isolated and concomitant AVR group respectively. There was no difference in survival between the two groups (log-rank test, P=0.4124). Conclusions Our results support the safety and efficacy of the Edwards INTUITY valve system even in complex aortic valve disease with additional cardiac procedures. RD-AVR could become a useful tool for concomitant surgeries where surgical times are expected to be prolonged.

show abstract

Section: Discussionmentioning

confidence: 54%